IQVIA Labs Genomics offers custom solutions for CAR Monitoring using Droplet Digital PCR. Our advanced technology ensures high sensitivity and specificity in detecting Chimeric Antigen Receptors (CAR) and Replication Competent Retrovirus (RCR) in cell therapy products, meeting FDA guidelines for limit of quantitation for cell and gene therapy products.
Ideal for clinical trials for hematological malignancies, our monitoring solutions empower discovery by correlating with RNA Seq expression profiles and clinical endpoints. With testing locations in RTP and Beijing, our flexible logistics offer validated solutions for retrospective testing on banked samples or rapid turnaround testing on samples shipped directly from clinical sites.
Trust IQVIA Labs Genomics for industry-leading expertise in CAR-T cell therapy monitoring using ddPCR.
Contact us today to learn more about how we can support your personalized immunotherapy needs and optimize your therapy monitoring process.
Download Document